For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. Veno-Arterial ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since Veno-Arterial ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Scope of the Report:
Europe region is the largest supplier of Veno-Arterial ECMO System, with a production market share nearly 42% in 2016. North America is the second largest supplier of Veno-Arterial ECMO System, enjoying production market share nearly 36% in 2016.
North America is the largest consumption place, with a consumption market share nearly 42% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic, Maquet, Sorin, Terumo and Xenios are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Veno-Arterial ECMO System is expected to grow at a CAGR of roughly xx% over the next five years, will reach 250 million US$ in 2024, from 250 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Veno-Arterial ECMO System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medtronic
- Maquet Holding
- Sorin Group
- Terumo
- Xenios AG
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Portable Type
- Fixed Type
Market Segment by Applications, can be divided into
- Neonatal
- Pediatric
- Adult
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veno-Arterial ECMO System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Veno-Arterial ECMO System, with price, sales, revenue and global market share of Veno-Arterial ECMO System in 2017 and 2018.
Chapter 3, the Veno-Arterial ECMO System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veno-Arterial ECMO System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Veno-Arterial ECMO System market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Veno-Arterial ECMO System sales channel, distributors, customers, research findings and conclusion, appendix and data source.